Relmada Therapeutics Inc (RLMD)
3.53
-0.30
(-7.83%)
USD |
NASDAQ |
Apr 29, 16:00
3.49
-0.04
(-1.13%)
Pre-Market: 09:01
Relmada Therapeutics EPS Diluted (TTM): -3.27 for Dec. 31, 2023
EPS Diluted (TTM) Chart
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -3.27 |
| September 30, 2023 | -3.70 |
| June 30, 2023 | -4.28 |
| March 31, 2023 | -4.77 |
| December 31, 2022 | -5.30 |
| September 30, 2022 | -5.84 |
| June 30, 2022 | -6.97 |
| March 31, 2022 | -7.20 |
| December 31, 2021 | -7.14 |
| September 30, 2021 | -6.63 |
| June 30, 2021 | -5.24 |
| March 31, 2021 | -4.41 |
| December 31, 2020 | -3.79 |
| September 30, 2020 | -2.88 |
| June 30, 2020 | -2.25 |
| March 31, 2020 | -1.88 |
| September 30, 2019 | -2.28 |
| June 30, 2019 | -2.98 |
| March 31, 2019 | -3.62 |
| December 31, 2018 | -4.30 |
| September 30, 2018 | -3.62 |
| June 30, 2018 | -2.86 |
| Date | Value |
|---|---|
| March 31, 2018 | -2.32 |
| December 31, 2017 | -1.92 |
| September 30, 2017 | -1.84 |
| June 30, 2017 | -2.08 |
| March 31, 2017 | -2.72 |
| December 31, 2016 | -2.68 |
| September 30, 2016 | -3.20 |
| June 30, 2016 | -1.20 |
| March 31, 2016 | 2.72 |
| December 31, 2015 | 2.40 |
| September 30, 2015 | 4.88 |
| June 30, 2015 | -11.20 |
| March 31, 2015 | -13.96 |
| December 31, 2014 | -13.05 |
| September 30, 2014 | -14.66 |
| February 28, 2014 | -0.0346 |
| November 30, 2013 | -0.0353 |
| August 31, 2013 | -0.0316 |
| May 31, 2013 | -0.029 |
| February 28, 2013 | -0.017 |
| November 30, 2012 | -0.0145 |
Earnings per Share Definition
Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.
EPS Diluted (TTM) Range, Past 5 Years
-7.20
Minimum
Mar 2022
-1.88
Maximum
Mar 2020
-4.489
Average
-4.345
Median
EPS Diluted (TTM) Benchmarks
| Cyclacel Pharmaceuticals Inc | -27.08 |
| Lifecore Biomedical Inc | -3.32 |
| Corvus Pharmaceuticals Inc | -0.56 |
| NeuroBo Pharmaceuticals Inc | -2.38 |
| Ensysce Biosciences Inc | -5.30 |